AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q3 2023 Earnings Call Transcript
Operator: Welcome to the AcelRx third quarter 2023 financial results conference call.
Posts Tagged ‘NASDAQ:ACRX’
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q2 2023 Earnings Call Transcript
Operator: Welcome to the AcelRx Second Quarter 2023 Financial Results Conference Call.
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q1 2023 Earnings Call Transcript
Operator: Hello, welcome to the AcelRx First Quarter 2023 Financial Results Conference Call.
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q4 2022 Earnings Call Transcript
Operator: Welcome to the AcelRx 2022 Full Year and Fourth Quarter Financial Results Conference Call.
5 Cheap Healthcare Stocks to Buy in 2023
In this piece, we will take a look at the twelve cheap healthcare stocks to buy in 2023. For more healthcare stocks, head on over to 12 Cheap Healthcare Stocks to Buy in 2023.
5. XORTX Therapeutics Inc. (NASDAQ:XRTX)
Latest P/E Ratio: 1.
5 Stocks with the Lowest PE Ratio
Catalyst Biosciences, Inc. (NASDAQ:CBIO) is a clinical-stage biotech company. In December, Catalyst Biosciences, Inc.
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q3 2022 Earnings Call Transcript
Operator: Welcome to the AcelRx Third Quarter 2022 Earnings Call.
10 Cheapest Stocks With Biggest Upside
In this article, we discuss the 10 cheapest stocks with the biggest upside.
Is AcelRx Pharmaceuticals (ACRX) A Good Stock To Buy Now?
In this article we are going to use hedge fund sentiment as a tool and determine whether AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) is a good investment right now.
Hedge Funds Have Never Been Less Bullish On AcelRx Pharmaceuticals Inc (ACRX)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Is AcelRx Pharmaceuticals Inc (ACRX) A Good Stock To Buy?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Hedge Funds Have Never Been More Bullish On AcelRx Pharmaceuticals Inc (ACRX)
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions of dollars of accredited...
Hedge Funds Are Crazy About AcelRx Pharmaceuticals Inc (ACRX)
Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter.
Does AcelRx Pharmaceuticals Inc (ACRX) Stack Up Against Its Peers?
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions...
McDonald’s Corporation (MCD), AcelRx Pharmaceuticals Inc. (ACRX) & More: Here’s Why These Stocks Are Trending Today
The US stock market is trading higher today as investors remain on the sidelines ahead of the Federal Reserve’s monetary policy meeting next week.
Should You Avoid AcelRx Pharmaceuticals Inc (ACRX)?
Is AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Why Is Joseph Edelman’s Hedge Fund So Bullish On AcelRx?
In a disclosure of its holdings, Joseph Edelman's Perceptive Advisors made public that it currently owns 6.57 million shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) last week...
Joseph Edelman, Perceptive Advisors Continue Bullish Streak in AcelRX Pharmaceuticals
Joseph Edelman's fund Perceptive Advisors continues its bullish streak on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) disclosing increasing its position to over 6.57 million shares...
Joseph Edelman’s Perceptive Advisors Buys More AcelRx Pharmaceuticals
Joseph Edelman's fund, Perceptive Advisors, in a new filing reported increasing its position in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) again, after disclosing a buy of around...
Joseph Edelman and Perceptive Advisors Buy 360,700 Shares of AcelRx Pharmaceuticals
Hedge fund Perceptive Advisors, founded and managed by Joseph Edelman, increased its position in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) by some 360,700 shares, to a total ...
AcelRx Pharmaceuticals Inc (ACRX): Long-Term Growth With Biotech Innovators
The global biotechnology industry is expected to reach $320 billion by 2015, up from $232 billion in 2012.
AcelRx Pharmaceuticals Inc (ACRX): Insiders Are Buying, Should You?
Is AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) a first-rate investment today? Hedge funds are getting less optimistic.
Hedge Funds Are Betting On Horizon Pharma Inc (HZNP)
To most investors, hedge funds are seen as slow, old investment tools of years past.
AcelRx Pharmaceuticals Inc (ACRX), Peregrine Pharmaceuticals (PPHM): This Week in Biotech
With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
AcelRx Pharmaceuticals Inc (ACRX): Hedge Funds and Insiders Are Bullish, What Should You Do?
Is AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) the right investment to pursue these days? Investors who are in the know are in an optimistic mood.
Hedge Funds Are Crazy About Zogenix, Inc. (ZGNX)
In today’s marketplace, there are a multitude of gauges shareholders can use to analyze the equity markets.
Horizon Pharma Inc (HZNP): Insiders Are Dumping, Should You?
According to most shareholders, hedge funds are perceived as unimportant, old financial vehicles of yesteryear.
ACADIA Pharmaceuticals Inc. (ACAD), Astex Pharmaceuticals, Inc. (ASTX), Pfizer Inc. (PFE), and More: This Week in Biotech
With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
